Ignite Creation Date:
2024-07-17 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06492304
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-21
Brief Title:
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With RelapsedRefractory Hematologic Malignancies
Sponsor:
CRISPR Therapeutics
Organization:
CRISPR Therapeutics
Organization Data
Organization:
CRISPR Therapeutics
Class:
INDUSTRY
Study ID:
CRSP-ONC-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CRISPR Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None